Luca’s CoughSearch® Debuts on Ant Group’s AQ Platform at Bund 2025 -Redefining Respiratory Diagnostics with AI

Shanghai, China September 13, 2025 – Luca Healthcare unveiled its flagship respiratory diagnostic tool, CoughSearch®, at the Inclusion-Bund Conference hosted by Ant Group. As one of the world’s most influential technology events, the Bund Conference highlights cutting-edge digital innovations driving transformation across AI and digital health. At the Future Health Pavilion, Luca unveiled its breakthrough…

Read more about Luca’s CoughSearch® Debuts on Ant Group’s AQ Platform at Bund 2025 -Redefining Respiratory Diagnostics with AI

Shanghai, China – July 25, 2025 – Luca Healthcare, a leader in developing predictive healthcare solutions using AI algorithms and machine learning, today announced that its groundbreaking research on an innovative AI algorithm for Chronic Obstructive Pulmonary Disease (COPD) diagnosis has been accepted for presentation at the prestigious European Respiratory Congress (ERS Congress) 2025. The presentation,…

Read more about Luca Healthcare to Unveil Game-Changing AI for COPD Diagnosis at European Respiratory Society Congress: A Leap in Acoustic Biomarker Science

August 22, Hangzhou, China — Luca Healthcare and SANTO Biotech (Hangzhou) Co., Ltd. have entered into a strategic partnership to co-develop cutting-edge AI-powered digital health technologies (DHT) for clinical applications in cell and gene therapies, including CAR-T, TCR-T, gene therapy, and gene editing. This collaboration will focus on integrating remote monitoring and patient-centric data capture…

Read more about Luca Healthcare and SANTO Biotech Forge Strategic Alliance to Advance AI-Enabled Safety Intelligence in In Vivo CAR-T Therapies

FOR IMMEDIATE RELEASE Ametris (formerly ActiGraph) and Luca Healthcare Announce Strategic Partnership to Accelerate Digital Health Solutions in Clinical Trials Across US and China Pensacola Florida, USA and Shanghai, China – August 25, 2025 – Ametris, a global digital health solutions provider transforming real-world patient data into validated clinical evidence, and Luca Healthcare, a leader in using…

Read more about Ametris (formerly ActiGraph) and Luca Healthcare Announce Strategic Partnership to Accelerate Digital Health Solutions in Clinical Trials Across US and China

12 Oct, 2021 SPH Health Commerce, the Direct-to-Patient (“DTP”) retail pharmacy subsidiary of Shanghai Pharmaceuticals and Luca Healthcare, China’s category leader in clinically validated, software-based screening, treatment and management tools, today announced a strategic partnership to provide Luca’s patient management platform of products with online medication refills and delivery capabilities through SPH’s internet hospital, 24×7…

Read more about Shanghai Pharmaceuticals and Luca Healthcare announce a strategic collaboration to provide home drug delivery to rare disease patients on Luca Healthcare’s patient management platform

10 Feb, 2022 Shanghai, February 10, 2022 – Sperogenix Therapeutics, a biopharma dedicated to developing and commercializing rare disease therapeutics in China and Luca Healthcare, China’s category leader in developing and maintaining regulated and clinically validated digital health solutions, today announced a strategic partnership to develop digital therapeutics for Sperogenix’s pipeline of rare disease treatments…

Read more about Sperogenix Therapeutics and Luca Healthcare announce a strategic collaboration to develop digital therapeutics for Sperogenix’s platform of rare disease treatments

29 Nov, 2022 Shanghai, Nov 28, 2022 – Cambridge Cognition, a leading technology company, which develops and markets digital solutions to assess brain health, and Luca Healthcare, China’s category leader in developing and commercializing clinically validated digital health solutions, today announces a strategic partnership and a 10-year exclusive licensing agreement to commercialize Cambridge Cognition’s suite…

Read more about Cambridge Cognition and Luca Healthcare announce a strategic partnership and an exclusive licensing agreement to commercialize Cambridge Cognition’s suite of cognitive assessment tools and brain health products for the China market

17 Feb, 2023 Shanghai, February 17, 2023 – Strategy&, the strategy consulting team at PwC and Luca Healthcare (“Luca”), a leader in developing clinically validated digital health solutions, today announced a strategic partnership to accelerate collaboration to build digital health solutions for life sciences companies. Dr. Echo Chen, CEO of Luca Healthcare, and Mr. William…

Read more about PwC (China) and Luca Healthcare announce a strategic partnership to accelerate collaboration to build digital health solutions for life sciences companies